The Japanese drugmaker said that Kim, president of its U.S. business unit, will succeed Chief Executive Christophe Weber, who ...
Takeda Pharmaceutical 4502-0.74%decrease; red down pointing triangle named Julie Kim, who heads its U.S. business, as its new chief executive starting in 2026, elevating her to the small but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback